Pegasus Partners Ltd. Ocugen, Inc. Transaction History
Pegasus Partners Ltd.
- $1.07 Billion
- Q3 2024
A detailed history of Pegasus Partners Ltd. transactions in Ocugen, Inc. stock. As of the latest transaction made, Pegasus Partners Ltd. holds 23,500 shares of OCGN stock, worth $23,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,500Holding current value
$23,500% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OCGN
# of Institutions
113Shares Held
72MCall Options Held
200KPut Options Held
151K-
Black Rock Inc. New York, NY17.9MShares$17.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.7MShares$16.7 Million0.0% of portfolio
-
State Street Corp Boston, MA5.93MShares$5.93 Million0.0% of portfolio
-
Ubs Group Ag4.37MShares$4.37 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$4.15 Million0.16% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $217M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...